The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period. This growth is primarily driven by the rising demand for biologics and ...
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...
The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted delivery systems using engineered carboxysomes, combining advanced ...
The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...
RESEARCHERS at Massachusetts Institute of Technology (MIT) have developed a method to purify gene therapies 10 times more quickly than conventional processes, paving the way to lower prices for the ...
Vietnam Investment Review on MSN
Fosun Pharma Announces 2025Q3 Financial Results
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
Global Location Strategies (GLS), one of the world's leading corporate site selection firms, today unveiled its 2026 Best Places for Pharmaceutical Manufacturing Insights Report. The report identifies ...
The Chosun Ilbo on MSN
Cosmax Unveils Vegan PDRN Through Biosynthesis
Global cosmetics ODM (research, development, and production) company Cosmax recently succeeded in diversifying the synthesis ...
Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...
Chile is home to one of the world’s largest salmon-farming industries, making it a vital hub for aquaculture vaccine demand. Salmon alone accounts for about 85 % of the vaccines used in Chile’s ...
Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results